Enhancing Surveillance Protocols for Acute Hepatitis C Virus Infection, Utah, 2014-2019

Nathaniel M Lewis1,2,3, Jeff Eason2, Bree Barbeau2

  • 1Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Insights

Utah enhanced its hepatitis C virus (HCV) surveillance, leading to a 14-fold increase in detected acute cases. Electronic and manual reporting of negative test results significantly improved case identification.

Area of Science:

  • Public Health
  • Infectious Disease Epidemiology
  • Viral Hepatitis Surveillance

Background:

  • Acute hepatitis C virus (HCV) infections pose a significant public health challenge.
  • Effective surveillance is crucial for understanding and controlling HCV transmission.
  • Previous surveillance methods in Utah may have underestimated the true incidence of acute HCV.

Purpose of the Study:

  • To describe the enhancements made to the Utah Department of Health's (UDOH) acute HCV surveillance program between 2014 and 2019.
  • To evaluate the impact of these enhancements on the detection of acute HCV infections.
  • To identify challenges and practical considerations for improving HCV surveillance.

Main Methods:

  • Mandatory electronic reporting of negative HCV and liver function test results.
  • Engagement with blood/plasma donation centers and syringe exchange programs for manual reporting.
  • Implementation of training for case investigations.
  • Analysis of case detection data from 2012 to 2019.

Main Results:

  • The number of detected acute HCV cases increased 14-fold, from 9 in 2012 to 127 in 2019.
  • In 2019, 55% of cases were identified through electronically reported negative HCV tests (recent seroconversions).
  • Manual reporting and positive test results with elevated liver function tests also contributed significantly to case detection.

Conclusions:

  • Enhancements to HCV surveillance, particularly electronic reporting of negative tests, dramatically increased case detection.
  • Collaboration with donation centers and syringe exchange programs is vital for comprehensive surveillance.
  • Utah's experience offers valuable insights for improving acute HCV surveillance programs elsewhere.